Sadeq Ahmed A, Hasan Syed Shahzad, AbouKhater Noha, Conway Barbara R, Abdelsalam Abeer E, Shamseddine Jinan M, Babiker Zahir Osman Eltahir, Nsutebu Emmanuel Fru, Bond Stuart E, Aldeyab Mamoon A
Department of Pharmacy, Shaikh Shakhbout Medical City in Partnership with Mayo Clinic, Abu Dhabi P.O. Box 11001, United Arab Emirates.
Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK.
Antibiotics (Basel). 2022 Sep 26;11(10):1306. doi: 10.3390/antibiotics11101306.
Antimicrobial stewardship interventions are targeted efforts by healthcare organizations to optimize antimicrobial use in clinical practice. The study aimed to explore effective interventions in improving antimicrobial use in hospitals. Literature was systemically searched for interventional studies through PubMed, CINAHL, and Scopus databases that were published in the period between January 2010 to April 2022. A random-effects model was used to pool and evaluate data from eligible studies that reported antimicrobial stewardship (AMS) interventions in outpatient and inpatient settings. Pooled estimates presented as proportions and standardized mean differences. Forty-eight articles were included in this review: 32 in inpatient and 16 in outpatient settings. Seventeen interventions have been identified, and eight outcomes have been targeted. AMS interventions improved clinical, microbiological, and cost outcomes in most studies. When comparing non-intervention with intervention groups using meta-analysis, there was an insignificant reduction in length of stay (MD: -0.99; 95% CI: -2.38, 0.39) and a significant reduction in antibiotics' days of therapy (MD: -2.73; 95% CI: -3.92, -1.54). There were noticeable reductions in readmissions, mortality rates, and antibiotic prescriptions post antimicrobial stewardship multi-disciplinary team (AMS-MDT) interventions. Studies that involved a pharmacist as part of the AMS-MDT showed more significant improvement in measured outcomes than the studies that did not involve a pharmacist.
抗菌药物管理干预措施是医疗机构为优化临床实践中抗菌药物使用而进行的针对性努力。该研究旨在探索改善医院抗菌药物使用的有效干预措施。通过PubMed、CINAHL和Scopus数据库系统检索了2010年1月至2022年4月期间发表的干预性研究文献。采用随机效应模型汇总和评估符合条件的研究数据,这些研究报告了门诊和住院环境中的抗菌药物管理(AMS)干预措施。汇总估计以比例和标准化均值差表示。本综述纳入了48篇文章:32篇关于住院患者,16篇关于门诊患者。确定了17种干预措施,并针对8种结果。在大多数研究中,AMS干预措施改善了临床、微生物学和成本结果。使用荟萃分析比较非干预组和干预组时,住院时间有不显著的缩短(MD:-0.99;95%CI:-2.38,0.39),抗生素治疗天数有显著缩短(MD:-2.73;95%CI:-3.92,-1.54)。抗菌药物管理多学科团队(AMS-MDT)干预后,再入院率、死亡率和抗生素处方量有明显下降。涉及药剂师作为AMS-MDT一部分的研究在测量结果方面比未涉及药剂师的研究显示出更显著的改善。